Positron Emission Tomography (PET) Imaging of Participants With Confirmed Prostate Cancer Using 64Cu-SAR-bisPSMA (PROPELLER)

Summary

The aim of this study is to determine the safety and tolerability of 64Cu-SARbisPSMA in participants with untreated, confirmed Prostate Cancer.

Timeline

Start

2021-07-13

Primary completion

2022-10-19

Completion

2022-10-19

Publications

• Lengyelova E, Patel M, Morrish G, Mittra E, Malaroda A, Gervasio O, Armor T. Optimization of Administered Activity for 64 Cu-SAR-bisPSMA PET Imaging in Primary Prostate Cancer: Results from a Phase I Retrospective Study (PROPELLER Sub-study). World J Nucl Med. 2026 Jun 23;25(2):107-114. doi: 10.1055/s-0046-1824335. eCollection 2026 Jun.

Drugs

Indications